Mandate

Vinge has acted as a Swedish local counsel to Krogerus in advising Caverion Oyj

November 12, 2019 M&A

Vinge has acted as a Swedish local counsel to Krogerus in advising Caverion Oyj, one of the Europe's leading provider of technical solutions for buildings and industries, on its acquisition of Huurre Finland Oy, including its subsidiary Huurre Sweden AB.

Caverion Suomi Oy has signed an agreement to acquire the entire share capital of Huurre Finland Oy from Huurre Group Oy. Huurre is a leading supplier of energy-efficient CO2 based refrigeration systems and related refrigeration automation solutions. Through its acquisition of Huurre Finland Oy, Caverion strengthens its technological offering in the Cooling business.

The Vinge team was led by partner Christina Kokko and included Anna Thoms, Vilhelm Rondahl and Viktor Lennartsson (M&A Corporate), Sophia Holm (Employment and Benefits), Hedvig Ekdahl (Commercial Agreements), Karolina Cohrs (Real Estate), Johan Karlsson, Trine Olsen Bergqvist, Sebastian Örndahl and Anna Grigorian (EU and Antitrust) and Jessica Öijer, Christoffer Widström and Nathalie Hughes (VDR).

 

Related

Vinge has advised Oncopeptides in connection with its rights issue

Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025

Vinge advises Main Capital and Unik in connection with the acquisition of LEB System Aktiebolag

Vinge has advised Unik International ApS (“Unik”), a Danish Housing and Property Management software provider, in connection with the acquisition of LEB System Aktiebolag. The synergistic acquisition is expected to complement and expand Unik’s offering and has a strong strategic fit with Unik and is in line with the company’s internationalization strategy in the Nordic Property Management software market.
August 28, 2025

Vinge has advised Xspray Pharma in connection with its rights issue and debt refinancing

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 130 million before transaction costs, with an over-allotment issue of approximately SEK 20 million, and refinancing of an existing loan.
August 28, 2025